活血化瘀药对肿瘤转移影响的多样性因素探讨  

Discussion on Diversity Factors of Blood-activating and Stasis-resolving Medicine Treating Cancer Metastasis

作　　者：唐德才[1] 臧文华[1] 朱叶琼[1] 李冰冰[1] 

机构地区：[1]南京中医药大学基础医学院,江苏南京210023

出　　处：《南京中医药大学学报》2013年第6期503-506,共4页Journal of Nanjing University of Traditional Chinese Medicine

基　　金：国家自然科学基金(81073072);南京中医药大学基础研究课题(10XJC01);江苏省高校优势学科建设工程一期项目南京中医药大学中医学一级学科开放课题(YS2012ZYX306)

摘　　要：活血化瘀药物为临床治疗肿瘤的常用药物。多数学者认为活血化瘀药尤其是破血药治疗恶性肿瘤有益,但也有学者认为应用该类药物会促进肿瘤的发生转移和扩散,使得对此类药物的应用争议较大。药理药效及临床实验提示,运用活血化瘀方药治疗恶性肿瘤符合中医辨证论治,活血化瘀药是在肿瘤防治过程中的必用之品。认为辨清肿瘤性质、部位,选用正确品种,采取恰当配伍,并根据中医辨证,择时使用,是活血化瘀药抗肿瘤侵袭、转移作用的关键因素。Blood-activating and stasis-resolving medicine is a common drug to treat tumors. Most scholars believe that blood -activating and stasis-resolving medicine, especially expelling blood circulation drugs, is effective to treat malignant tumor, while some scholars believe that the application of such drugs will promote tumor metastasis and diffusion. These drugs may have a positive or negative effect on cancer invasion and metastasis. It makes them more controversial. Through pharmacologi- cal experiment and clinical observation, blood-activating and stasis-resolving medicine conforms to differential diagnosis and treatment of TCM in treating malignant tumor. These drugs are essential in the prevention and treatment of cancer. To make blood-activating and stasis-resolving medicine produce anti-tumor invasion and metastasis, the key factors are discerning the na- ture and location of tumor, choosing the right breed, taking appropriate compatibility and selecting appropriate time according to TCM.

关 键 词：活血化瘀药 肿瘤 转移 影响因素 

分 类 号：R273[医药卫生—中西医结合]